1. Home
  2. HROW vs RBCAA Comparison

HROW vs RBCAA Comparison

Compare HROW & RBCAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • RBCAA
  • Stock Information
  • Founded
  • HROW 1998
  • RBCAA 1974
  • Country
  • HROW United States
  • RBCAA United States
  • Employees
  • HROW 382
  • RBCAA N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • RBCAA Major Banks
  • Sector
  • HROW Health Care
  • RBCAA Finance
  • Exchange
  • HROW Nasdaq
  • RBCAA Nasdaq
  • Market Cap
  • HROW 1.4B
  • RBCAA 1.3B
  • IPO Year
  • HROW N/A
  • RBCAA 1998
  • Fundamental
  • Price
  • HROW $39.22
  • RBCAA $77.02
  • Analyst Decision
  • HROW Strong Buy
  • RBCAA Hold
  • Analyst Count
  • HROW 7
  • RBCAA 1
  • Target Price
  • HROW $64.67
  • RBCAA N/A
  • AVG Volume (30 Days)
  • HROW 671.7K
  • RBCAA 24.6K
  • Earning Date
  • HROW 08-11-2025
  • RBCAA 10-17-2025
  • Dividend Yield
  • HROW N/A
  • RBCAA 2.35%
  • EPS Growth
  • HROW N/A
  • RBCAA 27.69
  • EPS
  • HROW N/A
  • RBCAA 6.28
  • Revenue
  • HROW $227,661,000.00
  • RBCAA $369,212,000.00
  • Revenue This Year
  • HROW $46.17
  • RBCAA $14.79
  • Revenue Next Year
  • HROW $39.97
  • RBCAA $10.26
  • P/E Ratio
  • HROW N/A
  • RBCAA $12.23
  • Revenue Growth
  • HROW 47.69
  • RBCAA 16.32
  • 52 Week Low
  • HROW $20.85
  • RBCAA $56.79
  • 52 Week High
  • HROW $59.23
  • RBCAA $80.68
  • Technical
  • Relative Strength Index (RSI)
  • HROW 62.35
  • RBCAA 68.78
  • Support Level
  • HROW $37.09
  • RBCAA $74.39
  • Resistance Level
  • HROW $39.67
  • RBCAA $77.34
  • Average True Range (ATR)
  • HROW 2.41
  • RBCAA 1.41
  • MACD
  • HROW 0.10
  • RBCAA 0.79
  • Stochastic Oscillator
  • HROW 87.23
  • RBCAA 96.66

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans and receipt and payment of federal.

Share on Social Networks: